Should I buy Copart (CPRT) stock or is it too late?

Copart · Industrials · price $26

⭐ What the most reliable analysts say · those who beat their sector, targets replayed on real prices

⭐ The most reliable of them, either direction: Barrington Research — 94% of its targets hit on this sector (35 calls tested). It aims for $40 (+52 %), call made on September 12, 2026, maturing on September 12, 2027 (32 d ago).

The 6 reliable analysts $37+40 %

The 2 other firms $39.50+50 %

How to read it: the 6 reliable firms are not filtered by optimism — 5 aim above the price, 1 below, hence their $37 median. “The 2 others” are the firms that don't pass our reliability filter on this sector.

Firm-by-firm track record on Copart

Here the hit rate is measured <b>on this stock specifically</b> (matured targets replayed against real prices, minimum 5 calls tested) — the green block above measures reliability <b>across the whole sector</b>, which is the criterion behind JPI selections. “Aims for” = the firm's most recent target on this stock; “—” means it hasn't published one recently.

Firm	% right	Gain vs sector	Calls	Aims for
Stephens & Co.	100 %	+30.4 %	7	$35 +33%
SunTrust Robinson Humphrey	80 %	+18.2 %	5	$23 -15%
Baird	67 %	+15.6 %	12	$38 +44%

In short — Should you invest in Copart? Is it too late, still worth it? Analysts are fairly positive (63% buy, median target $37, i.e. +40%), and the most reliable on CPRT targets even higher. But it pays virtually no dividend. We give you both sides, with the numbers — not advice.

✅ Reasons to believe

63% of analysts rate it a buy (Buy consensus, 8 ratings) — a sign of market conviction.
Median price target $37, i.e. +40% from the current price ($26).
The most reliable firm on CPRT, Stephens & Co. (100% hit rate, 7 scored calls), targets $35 (call made on August 20, 2026, maturing on August 20, 2027) (+33%) in its most recent call.
Reasonable valuation (P/E ~17) relative to its sector.

⚠️ Reasons to hesitate

The consensus is not unanimous: of 8 ratings, 2 are neutral and 1 is a sell.
A 12-month target is not a guaranteed path: the price can fall in the meantime.
No dividend: your return depends only on price appreciation.

The analyst consensus on CPRT

Median target $37 (+40%) · 8 ratings · Buy consensus

Strong Buy00%

Buy563%

Hold225%

Sell113%

Strong Sell00%

⚠️ Information, not investment advice. Past performance does not guarantee future results. Analyst targets on a ~12-month horizon.

Frequently asked questions

Should you invest in Copart now?

We won't decide for you. The facts: 63% of analysts rate it a buy, median target $37 (+40%), and Stephens & Co. (most reliable on CPRT, 100%) targets $35. Weigh that against valuation (P/E ~17). This is not personalized advice.

Is it too late to invest in Copart?

Not according to analysts: the median target ($37) is still +40% above the current price ($26) (most reliable on CPRT: Stephens & Co., 100%). The real question isn't "too late" but the price-to-value gap and risk. Not advice.

Is Copart still worth investing in?

It depends on the gap between the price ($26) and its estimated value: analysts target $37 on median (+40%), with 63% buys (most reliable on CPRT: Stephens & Co., 100%). Cross-check with their real reliability on CPRT and the cautions above. Information, not advice.

What's the main risk in buying CPRT?

The consensus is not unanimous: of 8 ratings, 2 are neutral and 1 is a sell.

→ Go deeper: the full Copart profile (consensus, analyst reliability, price target, performance).